Fresenius Medical Care Corporation (NYSE: FMS) reiterated to Hold by Societe Generale
Societe Generale reiterated Fresenius Medical Care Corporation (NYSE: FMS) to Hold.
Previously Societe Generale reiterated Fresenius Medical Care Corporation (NYSE: FMS) to Hold on 08/06/2013, when the stock price was $31.46.
Fresenius Medical Care AG & Co. KGaA (FMC-AG & Co. KGaA), is a kidney dialysis company, operating in both the field of dialysis products and the field of dialysis services. The Company?s dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. At December 31, 2008, it provided dialysis treatment to 184,086 patients in 2,388 clinics worldwide located in more than 30 countries. In the United States, it also performs clinical laboratory testing and provides inpatient dialysis services and other services under contract to hospitals. During the year ended December 31, 2008, it provided 27.9 million dialysis treatments. It also develops and manufactures a range of equipments, systems and disposable products, which it sells to customers in over 115 countries.